nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosinopril—Ramipril—type 2 diabetes mellitus	0.242	1	CrCtD
Fosinopril—hypertension—type 2 diabetes mellitus	0.203	1	CtDrD
Fosinopril—ACE—type 2 diabetes mellitus	0.0994	1	CbGaD
Fosinopril—ACE—Ramipril—type 2 diabetes mellitus	0.0317	0.169	CbGbCtD
Fosinopril—Mitiglinide—Nateglinide—type 2 diabetes mellitus	0.0205	0.109	CrCrCtD
Fosinopril—ACE—Losartan—type 2 diabetes mellitus	0.0187	0.0998	CbGbCtD
Fosinopril—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.0186	0.0993	CbGbCtD
Fosinopril—Cilazapril—Nateglinide—type 2 diabetes mellitus	0.0177	0.094	CrCrCtD
Fosinopril—Spirapril—Nateglinide—type 2 diabetes mellitus	0.0177	0.094	CrCrCtD
Fosinopril—Lisinopril—Nateglinide—type 2 diabetes mellitus	0.0177	0.094	CrCrCtD
Fosinopril—Trandolapril—Nateglinide—type 2 diabetes mellitus	0.0166	0.0882	CrCrCtD
Fosinopril—Ramipril—Nateglinide—type 2 diabetes mellitus	0.0166	0.0882	CrCrCtD
Fosinopril—Enalapril—Nateglinide—type 2 diabetes mellitus	0.0166	0.0882	CrCrCtD
Fosinopril—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.0166	0.0885	CbGbCtD
Fosinopril—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.016	0.0855	CbGbCtD
Fosinopril—SLC15A2—Ramipril—type 2 diabetes mellitus	0.0148	0.0789	CbGbCtD
Fosinopril—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0143	0.0762	CbGbCtD
Fosinopril—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0141	0.0752	CbGbCtD
Fosinopril—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0127	0.0679	CbGbCtD
Fosinopril—Mitiglinide—Ramipril—type 2 diabetes mellitus	0.0125	0.0661	CrCrCtD
Fosinopril—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0121	0.0648	CbGbCtD
Fosinopril—Spirapril—Ramipril—type 2 diabetes mellitus	0.0108	0.0572	CrCrCtD
Fosinopril—Lisinopril—Ramipril—type 2 diabetes mellitus	0.0108	0.0572	CrCrCtD
Fosinopril—Cilazapril—Ramipril—type 2 diabetes mellitus	0.0108	0.0572	CrCrCtD
Fosinopril—Trandolapril—Ramipril—type 2 diabetes mellitus	0.0101	0.0536	CrCrCtD
Fosinopril—Enalapril—Ramipril—type 2 diabetes mellitus	0.0101	0.0536	CrCrCtD
Fosinopril—SLC15A2—Glyburide—type 2 diabetes mellitus	0.00952	0.0508	CbGbCtD
Fosinopril—SLC15A1—Glyburide—type 2 diabetes mellitus	0.0082	0.0438	CbGbCtD
Fosinopril—ACE—arteriole—type 2 diabetes mellitus	0.0028	0.163	CbGeAlD
Fosinopril—ACE—forelimb zeugopod—type 2 diabetes mellitus	0.00245	0.143	CbGeAlD
Fosinopril—ACE—tunica intima—type 2 diabetes mellitus	0.00199	0.116	CbGeAlD
Fosinopril—ACE—sympathetic nervous system—type 2 diabetes mellitus	0.00178	0.104	CbGeAlD
Fosinopril—ACE—autonomic nervous system—type 2 diabetes mellitus	0.0012	0.0697	CbGeAlD
Fosinopril—ACE—hindlimb—type 2 diabetes mellitus	0.00111	0.0645	CbGeAlD
Fosinopril—ACE—peripheral nervous system—type 2 diabetes mellitus	0.000864	0.0503	CbGeAlD
Fosinopril—ACE—artery—type 2 diabetes mellitus	0.000679	0.0395	CbGeAlD
Fosinopril—ACE—nerve—type 2 diabetes mellitus	0.000674	0.0392	CbGeAlD
Fosinopril—ACE—endothelium—type 2 diabetes mellitus	0.000574	0.0334	CbGeAlD
Fosinopril—ACE—ACE Inhibitor Pathway—AGTR2—type 2 diabetes mellitus	0.000369	0.0664	CbGpPWpGaD
Fosinopril—SLC15A1—nephron tubule—type 2 diabetes mellitus	0.000367	0.0213	CbGeAlD
Fosinopril—ACE—Peptide hormone metabolism—PCSK2—type 2 diabetes mellitus	0.000359	0.0646	CbGpPWpGaD
Fosinopril—SLC15A1—kidney—type 2 diabetes mellitus	0.000322	0.0188	CbGeAlD
Fosinopril—Mitiglinide—ABCC8—type 2 diabetes mellitus	0.000271	0.231	CrCbGaD
Fosinopril—ACE—nephron tubule—type 2 diabetes mellitus	0.000263	0.0153	CbGeAlD
Fosinopril—SLC15A2—retina—type 2 diabetes mellitus	0.000243	0.0142	CbGeAlD
Fosinopril—ACE—cardiovascular system—type 2 diabetes mellitus	0.000236	0.0137	CbGeAlD
Fosinopril—ACE—kidney—type 2 diabetes mellitus	0.000231	0.0134	CbGeAlD
Fosinopril—SLC15A2—nephron tubule—type 2 diabetes mellitus	0.000229	0.0133	CbGeAlD
Fosinopril—ACE—cortex of kidney—type 2 diabetes mellitus	0.000225	0.0131	CbGeAlD
Fosinopril—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—type 2 diabetes mellitus	0.000209	0.0377	CbGpPWpGaD
Fosinopril—ACE—adipose tissue—type 2 diabetes mellitus	0.000208	0.0121	CbGeAlD
Fosinopril—SLC15A1—liver—type 2 diabetes mellitus	0.000204	0.0119	CbGeAlD
Fosinopril—SLC15A2—kidney—type 2 diabetes mellitus	0.000201	0.0117	CbGeAlD
Fosinopril—ACE—ACE Inhibitor Pathway—AGT—type 2 diabetes mellitus	0.0002	0.0359	CbGpPWpGaD
Fosinopril—SLC15A2—cortex of kidney—type 2 diabetes mellitus	0.000196	0.0114	CbGeAlD
Fosinopril—Mitiglinide—KCNJ11—type 2 diabetes mellitus	0.000191	0.163	CrCbGaD
Fosinopril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.000183	0.0329	CbGpPWpGaD
Fosinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.000169	0.0305	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—SLC30A8—type 2 diabetes mellitus	0.000168	0.0302	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—DPP4—type 2 diabetes mellitus	0.000168	0.0302	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—GIP—type 2 diabetes mellitus	0.000162	0.0291	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—PCSK1—type 2 diabetes mellitus	0.000156	0.0281	CbGpPWpGaD
Fosinopril—ACE—ACE Inhibitor Pathway—NOS3—type 2 diabetes mellitus	0.000146	0.0264	CbGpPWpGaD
Fosinopril—ACE—liver—type 2 diabetes mellitus	0.000146	0.0085	CbGeAlD
Fosinopril—Spirapril—ACE—type 2 diabetes mellitus	0.000111	0.0944	CrCbGaD
Fosinopril—Mitiglinide—PPARG—type 2 diabetes mellitus	0.000106	0.0902	CrCbGaD
Fosinopril—Cilazapril—ACE—type 2 diabetes mellitus	9.89e-05	0.0841	CrCbGaD
Fosinopril—Lisinopril—ACE—type 2 diabetes mellitus	9.89e-05	0.0841	CrCbGaD
Fosinopril—ACE—Peptide hormone metabolism—PAX6—type 2 diabetes mellitus	9.8e-05	0.0176	CbGpPWpGaD
Fosinopril—ACE—ACE Inhibitor Pathway—TGFB1—type 2 diabetes mellitus	9.69e-05	0.0174	CbGpPWpGaD
Fosinopril—Trandolapril—ACE—type 2 diabetes mellitus	9.58e-05	0.0815	CrCbGaD
Fosinopril—Ramipril—ACE—type 2 diabetes mellitus	9.58e-05	0.0815	CrCbGaD
Fosinopril—ACE—Peptide hormone metabolism—GHRL—type 2 diabetes mellitus	8.97e-05	0.0161	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—TCF7L2—type 2 diabetes mellitus	8.34e-05	0.015	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—GCG—type 2 diabetes mellitus	8.2e-05	0.0148	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	8.16e-05	0.0147	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	7.57e-05	0.0136	CbGpPWpGaD
Fosinopril—Enalapril—ACE—type 2 diabetes mellitus	7.26e-05	0.0618	CrCbGaD
Fosinopril—ACE—Peptide hormone metabolism—GNB3—type 2 diabetes mellitus	7.07e-05	0.0127	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—PCSK2—type 2 diabetes mellitus	6.77e-05	0.0122	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—WFS1—type 2 diabetes mellitus	6.04e-05	0.0109	CbGpPWpGaD
Fosinopril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	5.88e-05	0.0106	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—AGT—type 2 diabetes mellitus	5.51e-05	0.00991	CbGpPWpGaD
Fosinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	5.46e-05	0.00982	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	5.44e-05	0.0098	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—LEP—type 2 diabetes mellitus	5.4e-05	0.00971	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	5.26e-05	0.00947	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	5.05e-05	0.0091	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	4.88e-05	0.00878	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—INS—type 2 diabetes mellitus	4.61e-05	0.0083	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—IGF1—type 2 diabetes mellitus	4.46e-05	0.00803	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	4.29e-05	0.00772	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	4.15e-05	0.00746	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	4.13e-05	0.00743	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	3.98e-05	0.00716	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—ADAMTS9—type 2 diabetes mellitus	3.89e-05	0.007	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	3.85e-05	0.00693	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	3.83e-05	0.00689	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	3.51e-05	0.00632	CbGpPWpGaD
Fosinopril—Enalapril—CYP3A4—type 2 diabetes mellitus	3.41e-05	0.029	CrCbGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	3.39e-05	0.0061	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	3.26e-05	0.00586	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—SLC30A8—type 2 diabetes mellitus	3.17e-05	0.00571	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—DPP4—type 2 diabetes mellitus	3.17e-05	0.00571	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	3.14e-05	0.00566	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—GIP—type 2 diabetes mellitus	3.05e-05	0.0055	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—PCSK1—type 2 diabetes mellitus	2.95e-05	0.00531	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—ST6GAL1—type 2 diabetes mellitus	2.86e-05	0.00514	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	2.82e-05	0.00508	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	2.77e-05	0.00498	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	2.69e-05	0.00485	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	2.67e-05	0.00481	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	2.67e-05	0.00481	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	2.63e-05	0.00473	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	2.62e-05	0.00471	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	2.57e-05	0.00462	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	2.5e-05	0.0045	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	2.48e-05	0.00446	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	2.48e-05	0.00446	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	2.44e-05	0.0044	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	2.44e-05	0.00439	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	2.27e-05	0.00408	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.18e-05	0.00393	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.18e-05	0.00392	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.18e-05	0.00392	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—ATF3—type 2 diabetes mellitus	2.12e-05	0.00381	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.1e-05	0.00377	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.1e-05	0.00377	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.09e-05	0.00377	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.06e-05	0.00371	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.03e-05	0.00365	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.02e-05	0.00364	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.02e-05	0.00364	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	1.95e-05	0.0035	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	1.95e-05	0.0035	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	1.94e-05	0.0035	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	1.91e-05	0.00344	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	1.9e-05	0.00343	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—F7—type 2 diabetes mellitus	1.9e-05	0.00342	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—PAX6—type 2 diabetes mellitus	1.85e-05	0.00333	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.78e-05	0.00321	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	1.78e-05	0.0032	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	1.77e-05	0.00318	CbGpPWpGaD
Fosinopril—Anaemia—Losartan—type 2 diabetes mellitus	1.77e-05	0.000313	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	1.76e-05	0.000311	CcSEcCtD
Fosinopril—Agitation—Losartan—type 2 diabetes mellitus	1.76e-05	0.000311	CcSEcCtD
Fosinopril—Oedema—Metformin—type 2 diabetes mellitus	1.76e-05	0.000311	CcSEcCtD
Fosinopril—Tinnitus—Ramipril—type 2 diabetes mellitus	1.75e-05	0.000311	CcSEcCtD
Fosinopril—Hypertension—Irbesartan—type 2 diabetes mellitus	1.75e-05	0.00031	CcSEcCtD
Fosinopril—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	1.75e-05	0.00031	CcSEcCtD
Fosinopril—Flushing—Ramipril—type 2 diabetes mellitus	1.75e-05	0.000309	CcSEcCtD
Fosinopril—Angioedema—Losartan—type 2 diabetes mellitus	1.75e-05	0.000309	CcSEcCtD
Fosinopril—Infection—Metformin—type 2 diabetes mellitus	1.74e-05	0.000309	CcSEcCtD
Fosinopril—Insomnia—Valsartan—type 2 diabetes mellitus	1.74e-05	0.000309	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	1.74e-05	0.000307	CcSEcCtD
Fosinopril—Paraesthesia—Valsartan—type 2 diabetes mellitus	1.73e-05	0.000307	CcSEcCtD
Fosinopril—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	1.73e-05	0.000306	CcSEcCtD
Fosinopril—Chest pain—Irbesartan—type 2 diabetes mellitus	1.73e-05	0.000306	CcSEcCtD
Fosinopril—Myalgia—Irbesartan—type 2 diabetes mellitus	1.73e-05	0.000306	CcSEcCtD
Fosinopril—Arthralgia—Irbesartan—type 2 diabetes mellitus	1.73e-05	0.000306	CcSEcCtD
Fosinopril—Shock—Metformin—type 2 diabetes mellitus	1.73e-05	0.000306	CcSEcCtD
Fosinopril—Insomnia—Orlistat—type 2 diabetes mellitus	1.72e-05	0.000305	CcSEcCtD
Fosinopril—Malaise—Losartan—type 2 diabetes mellitus	1.72e-05	0.000305	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.72e-05	0.0031	CbGpPWpGaD
Fosinopril—Hypersensitivity—Glyburide—type 2 diabetes mellitus	1.72e-05	0.000305	CcSEcCtD
Fosinopril—Thrombocytopenia—Metformin—type 2 diabetes mellitus	1.72e-05	0.000304	CcSEcCtD
Fosinopril—Dyspnoea—Valsartan—type 2 diabetes mellitus	1.72e-05	0.000304	CcSEcCtD
Fosinopril—Vertigo—Losartan—type 2 diabetes mellitus	1.72e-05	0.000304	CcSEcCtD
Fosinopril—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	1.72e-05	0.000304	CcSEcCtD
Fosinopril—Somnolence—Valsartan—type 2 diabetes mellitus	1.71e-05	0.000304	CcSEcCtD
Fosinopril—Syncope—Losartan—type 2 diabetes mellitus	1.71e-05	0.000303	CcSEcCtD
Fosinopril—Paraesthesia—Orlistat—type 2 diabetes mellitus	1.71e-05	0.000303	CcSEcCtD
Fosinopril—Leukopenia—Losartan—type 2 diabetes mellitus	1.71e-05	0.000303	CcSEcCtD
Fosinopril—Discomfort—Irbesartan—type 2 diabetes mellitus	1.71e-05	0.000302	CcSEcCtD
Fosinopril—Hyperhidrosis—Metformin—type 2 diabetes mellitus	1.7e-05	0.000301	CcSEcCtD
Fosinopril—Dyspepsia—Valsartan—type 2 diabetes mellitus	1.7e-05	0.000301	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—GHRL—type 2 diabetes mellitus	1.69e-05	0.00305	CbGpPWpGaD
Fosinopril—Dizziness—Bromocriptine—type 2 diabetes mellitus	1.69e-05	0.000299	CcSEcCtD
Fosinopril—Dry mouth—Irbesartan—type 2 diabetes mellitus	1.69e-05	0.000299	CcSEcCtD
Fosinopril—Palpitations—Losartan—type 2 diabetes mellitus	1.69e-05	0.000299	CcSEcCtD
Fosinopril—Nausea—Glimepiride—type 2 diabetes mellitus	1.68e-05	0.000298	CcSEcCtD
Fosinopril—Arrhythmia—Ramipril—type 2 diabetes mellitus	1.68e-05	0.000298	CcSEcCtD
Fosinopril—Loss of consciousness—Losartan—type 2 diabetes mellitus	1.68e-05	0.000297	CcSEcCtD
Fosinopril—Nausea—Sitagliptin—type 2 diabetes mellitus	1.68e-05	0.000297	CcSEcCtD
Fosinopril—Dyspepsia—Orlistat—type 2 diabetes mellitus	1.68e-05	0.000297	CcSEcCtD
Fosinopril—Asthenia—Glyburide—type 2 diabetes mellitus	1.68e-05	0.000297	CcSEcCtD
Fosinopril—Decreased appetite—Valsartan—type 2 diabetes mellitus	1.68e-05	0.000297	CcSEcCtD
Fosinopril—Anorexia—Metformin—type 2 diabetes mellitus	1.67e-05	0.000296	CcSEcCtD
Fosinopril—Cough—Losartan—type 2 diabetes mellitus	1.67e-05	0.000295	CcSEcCtD
Fosinopril—Urticaria—Gliclazide—type 2 diabetes mellitus	1.67e-05	0.000295	CcSEcCtD
Fosinopril—Fatigue—Valsartan—type 2 diabetes mellitus	1.66e-05	0.000294	CcSEcCtD
Fosinopril—Body temperature increased—Gliclazide—type 2 diabetes mellitus	1.66e-05	0.000294	CcSEcCtD
Fosinopril—Abdominal pain—Gliclazide—type 2 diabetes mellitus	1.66e-05	0.000294	CcSEcCtD
Fosinopril—Oedema—Irbesartan—type 2 diabetes mellitus	1.66e-05	0.000293	CcSEcCtD
Fosinopril—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	1.66e-05	0.000293	CcSEcCtD
Fosinopril—Decreased appetite—Orlistat—type 2 diabetes mellitus	1.66e-05	0.000293	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.65e-05	0.00298	CbGpPWpGaD
Fosinopril—Pruritus—Glyburide—type 2 diabetes mellitus	1.65e-05	0.000293	CcSEcCtD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	1.65e-05	0.00297	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.65e-05	0.00297	CbGpPWpGaD
Fosinopril—Constipation—Valsartan—type 2 diabetes mellitus	1.65e-05	0.000292	CcSEcCtD
Fosinopril—Infection—Irbesartan—type 2 diabetes mellitus	1.65e-05	0.000291	CcSEcCtD
Fosinopril—Fatigue—Orlistat—type 2 diabetes mellitus	1.64e-05	0.000291	CcSEcCtD
Fosinopril—Hypotension—Metformin—type 2 diabetes mellitus	1.64e-05	0.000291	CcSEcCtD
Fosinopril—Shock—Irbesartan—type 2 diabetes mellitus	1.63e-05	0.000289	CcSEcCtD
Fosinopril—Pain—Orlistat—type 2 diabetes mellitus	1.63e-05	0.000288	CcSEcCtD
Fosinopril—Myalgia—Losartan—type 2 diabetes mellitus	1.63e-05	0.000288	CcSEcCtD
Fosinopril—Chest pain—Losartan—type 2 diabetes mellitus	1.63e-05	0.000288	CcSEcCtD
Fosinopril—Arthralgia—Losartan—type 2 diabetes mellitus	1.63e-05	0.000288	CcSEcCtD
Fosinopril—Vomiting—Bromocriptine—type 2 diabetes mellitus	1.62e-05	0.000288	CcSEcCtD
Fosinopril—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	1.62e-05	0.000287	CcSEcCtD
Fosinopril—Tachycardia—Irbesartan—type 2 diabetes mellitus	1.62e-05	0.000286	CcSEcCtD
Fosinopril—Rash—Bromocriptine—type 2 diabetes mellitus	1.61e-05	0.000285	CcSEcCtD
Fosinopril—Dermatitis—Bromocriptine—type 2 diabetes mellitus	1.61e-05	0.000285	CcSEcCtD
Fosinopril—Tension—Ramipril—type 2 diabetes mellitus	1.61e-05	0.000285	CcSEcCtD
Fosinopril—Discomfort—Losartan—type 2 diabetes mellitus	1.61e-05	0.000285	CcSEcCtD
Fosinopril—Dysgeusia—Ramipril—type 2 diabetes mellitus	1.6e-05	0.000284	CcSEcCtD
Fosinopril—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	1.6e-05	0.000284	CcSEcCtD
Fosinopril—Headache—Bromocriptine—type 2 diabetes mellitus	1.6e-05	0.000284	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	1.6e-05	0.000283	CcSEcCtD
Fosinopril—Diarrhoea—Glyburide—type 2 diabetes mellitus	1.6e-05	0.000283	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.6e-05	0.00288	CbGpPWpGaD
Fosinopril—Nervousness—Ramipril—type 2 diabetes mellitus	1.59e-05	0.000282	CcSEcCtD
Fosinopril—Dry mouth—Losartan—type 2 diabetes mellitus	1.59e-05	0.000282	CcSEcCtD
Fosinopril—Anorexia—Irbesartan—type 2 diabetes mellitus	1.58e-05	0.00028	CcSEcCtD
Fosinopril—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	1.58e-05	0.000279	CcSEcCtD
Fosinopril—Paraesthesia—Metformin—type 2 diabetes mellitus	1.58e-05	0.000279	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	1.58e-05	0.00284	CbGpPWpGaD
Fosinopril—Muscle spasms—Ramipril—type 2 diabetes mellitus	1.57e-05	0.000279	CcSEcCtD
Fosinopril—Confusional state—Losartan—type 2 diabetes mellitus	1.57e-05	0.000278	CcSEcCtD
Fosinopril—Feeling abnormal—Orlistat—type 2 diabetes mellitus	1.57e-05	0.000278	CcSEcCtD
Fosinopril—Dyspnoea—Metformin—type 2 diabetes mellitus	1.56e-05	0.000277	CcSEcCtD
Fosinopril—Somnolence—Metformin—type 2 diabetes mellitus	1.56e-05	0.000276	CcSEcCtD
Fosinopril—Oedema—Losartan—type 2 diabetes mellitus	1.56e-05	0.000276	CcSEcCtD
Fosinopril—Anaphylactic shock—Losartan—type 2 diabetes mellitus	1.56e-05	0.000276	CcSEcCtD
Fosinopril—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	1.56e-05	0.000276	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—GCG—type 2 diabetes mellitus	1.55e-05	0.00279	CbGpPWpGaD
Fosinopril—Infection—Losartan—type 2 diabetes mellitus	1.55e-05	0.000274	CcSEcCtD
Fosinopril—Hypotension—Irbesartan—type 2 diabetes mellitus	1.55e-05	0.000274	CcSEcCtD
Fosinopril—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	1.55e-05	0.000274	CcSEcCtD
Fosinopril—Dyspepsia—Metformin—type 2 diabetes mellitus	1.54e-05	0.000274	CcSEcCtD
Fosinopril—Tremor—Ramipril—type 2 diabetes mellitus	1.53e-05	0.000272	CcSEcCtD
Fosinopril—Shock—Losartan—type 2 diabetes mellitus	1.53e-05	0.000272	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.53e-05	0.00276	CbGpPWpGaD
Fosinopril—Urticaria—Valsartan—type 2 diabetes mellitus	1.53e-05	0.000271	CcSEcCtD
Fosinopril—Thrombocytopenia—Losartan—type 2 diabetes mellitus	1.53e-05	0.00027	CcSEcCtD
Fosinopril—Decreased appetite—Metformin—type 2 diabetes mellitus	1.53e-05	0.00027	CcSEcCtD
Fosinopril—Abdominal pain—Valsartan—type 2 diabetes mellitus	1.52e-05	0.00027	CcSEcCtD
Fosinopril—Tachycardia—Losartan—type 2 diabetes mellitus	1.52e-05	0.000269	CcSEcCtD
Fosinopril—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	1.52e-05	0.000269	CcSEcCtD
Fosinopril—Nausea—Bromocriptine—type 2 diabetes mellitus	1.52e-05	0.000269	CcSEcCtD
Fosinopril—Fatigue—Metformin—type 2 diabetes mellitus	1.51e-05	0.000268	CcSEcCtD
Fosinopril—Urticaria—Orlistat—type 2 diabetes mellitus	1.51e-05	0.000268	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	1.51e-05	0.000267	CcSEcCtD
Fosinopril—Hyperhidrosis—Losartan—type 2 diabetes mellitus	1.51e-05	0.000267	CcSEcCtD
Fosinopril—Abdominal pain—Orlistat—type 2 diabetes mellitus	1.51e-05	0.000267	CcSEcCtD
Fosinopril—Body temperature increased—Orlistat—type 2 diabetes mellitus	1.51e-05	0.000267	CcSEcCtD
Fosinopril—Asthenia—Gliclazide—type 2 diabetes mellitus	1.51e-05	0.000267	CcSEcCtD
Fosinopril—Agitation—Ramipril—type 2 diabetes mellitus	1.5e-05	0.000267	CcSEcCtD
Fosinopril—Constipation—Metformin—type 2 diabetes mellitus	1.5e-05	0.000266	CcSEcCtD
Fosinopril—Angioedema—Ramipril—type 2 diabetes mellitus	1.5e-05	0.000265	CcSEcCtD
Fosinopril—Paraesthesia—Irbesartan—type 2 diabetes mellitus	1.49e-05	0.000263	CcSEcCtD
Fosinopril—Anorexia—Losartan—type 2 diabetes mellitus	1.49e-05	0.000263	CcSEcCtD
Fosinopril—Vomiting—Glyburide—type 2 diabetes mellitus	1.49e-05	0.000263	CcSEcCtD
Fosinopril—Pruritus—Gliclazide—type 2 diabetes mellitus	1.48e-05	0.000263	CcSEcCtD
Fosinopril—Malaise—Ramipril—type 2 diabetes mellitus	1.48e-05	0.000262	CcSEcCtD
Fosinopril—Dyspnoea—Irbesartan—type 2 diabetes mellitus	1.48e-05	0.000262	CcSEcCtD
Fosinopril—Rash—Glyburide—type 2 diabetes mellitus	1.47e-05	0.000261	CcSEcCtD
Fosinopril—Somnolence—Irbesartan—type 2 diabetes mellitus	1.47e-05	0.000261	CcSEcCtD
Fosinopril—Dermatitis—Glyburide—type 2 diabetes mellitus	1.47e-05	0.000261	CcSEcCtD
Fosinopril—Vertigo—Ramipril—type 2 diabetes mellitus	1.47e-05	0.000261	CcSEcCtD
Fosinopril—Syncope—Ramipril—type 2 diabetes mellitus	1.47e-05	0.00026	CcSEcCtD
Fosinopril—Leukopenia—Ramipril—type 2 diabetes mellitus	1.47e-05	0.00026	CcSEcCtD
Fosinopril—Headache—Glyburide—type 2 diabetes mellitus	1.46e-05	0.000259	CcSEcCtD
Fosinopril—Dyspepsia—Irbesartan—type 2 diabetes mellitus	1.46e-05	0.000258	CcSEcCtD
Fosinopril—Hypotension—Losartan—type 2 diabetes mellitus	1.46e-05	0.000258	CcSEcCtD
Fosinopril—Palpitations—Ramipril—type 2 diabetes mellitus	1.45e-05	0.000256	CcSEcCtD
Fosinopril—Feeling abnormal—Metformin—type 2 diabetes mellitus	1.45e-05	0.000256	CcSEcCtD
Fosinopril—Decreased appetite—Irbesartan—type 2 diabetes mellitus	1.44e-05	0.000255	CcSEcCtD
Fosinopril—Loss of consciousness—Ramipril—type 2 diabetes mellitus	1.44e-05	0.000255	CcSEcCtD
Fosinopril—Diarrhoea—Gliclazide—type 2 diabetes mellitus	1.44e-05	0.000254	CcSEcCtD
Fosinopril—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	1.44e-05	0.000254	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.43e-05	0.00258	CbGpPWpGaD
Fosinopril—Cough—Ramipril—type 2 diabetes mellitus	1.43e-05	0.000253	CcSEcCtD
Fosinopril—Fatigue—Irbesartan—type 2 diabetes mellitus	1.43e-05	0.000253	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	1.42e-05	0.000252	CcSEcCtD
Fosinopril—Hypersensitivity—Valsartan—type 2 diabetes mellitus	1.42e-05	0.000252	CcSEcCtD
Fosinopril—Pain—Irbesartan—type 2 diabetes mellitus	1.42e-05	0.000251	CcSEcCtD
Fosinopril—Constipation—Irbesartan—type 2 diabetes mellitus	1.42e-05	0.000251	CcSEcCtD
Fosinopril—Insomnia—Losartan—type 2 diabetes mellitus	1.41e-05	0.00025	CcSEcCtD
Fosinopril—Hypersensitivity—Orlistat—type 2 diabetes mellitus	1.4e-05	0.000249	CcSEcCtD
Fosinopril—Paraesthesia—Losartan—type 2 diabetes mellitus	1.4e-05	0.000248	CcSEcCtD
Fosinopril—Urticaria—Metformin—type 2 diabetes mellitus	1.39e-05	0.000247	CcSEcCtD
Fosinopril—Arthralgia—Ramipril—type 2 diabetes mellitus	1.39e-05	0.000247	CcSEcCtD
Fosinopril—Myalgia—Ramipril—type 2 diabetes mellitus	1.39e-05	0.000247	CcSEcCtD
Fosinopril—Chest pain—Ramipril—type 2 diabetes mellitus	1.39e-05	0.000247	CcSEcCtD
Fosinopril—Dyspnoea—Losartan—type 2 diabetes mellitus	1.39e-05	0.000246	CcSEcCtD
Fosinopril—Nausea—Glyburide—type 2 diabetes mellitus	1.39e-05	0.000246	CcSEcCtD
Fosinopril—Abdominal pain—Metformin—type 2 diabetes mellitus	1.39e-05	0.000246	CcSEcCtD
Fosinopril—Dizziness—Gliclazide—type 2 diabetes mellitus	1.39e-05	0.000246	CcSEcCtD
Fosinopril—Somnolence—Losartan—type 2 diabetes mellitus	1.39e-05	0.000245	CcSEcCtD
Fosinopril—Asthenia—Valsartan—type 2 diabetes mellitus	1.38e-05	0.000245	CcSEcCtD
Fosinopril—Discomfort—Ramipril—type 2 diabetes mellitus	1.38e-05	0.000244	CcSEcCtD
Fosinopril—Dyspepsia—Losartan—type 2 diabetes mellitus	1.37e-05	0.000243	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.37e-05	0.00246	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.37e-05	0.00246	CbGpPWpGaD
Fosinopril—Asthenia—Orlistat—type 2 diabetes mellitus	1.37e-05	0.000242	CcSEcCtD
Fosinopril—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	1.36e-05	0.000242	CcSEcCtD
Fosinopril—Pruritus—Valsartan—type 2 diabetes mellitus	1.36e-05	0.000242	CcSEcCtD
Fosinopril—Dry mouth—Ramipril—type 2 diabetes mellitus	1.36e-05	0.000242	CcSEcCtD
Fosinopril—Decreased appetite—Losartan—type 2 diabetes mellitus	1.35e-05	0.00024	CcSEcCtD
Fosinopril—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	1.35e-05	0.00024	CcSEcCtD
Fosinopril—Confusional state—Ramipril—type 2 diabetes mellitus	1.35e-05	0.000239	CcSEcCtD
Fosinopril—Pruritus—Orlistat—type 2 diabetes mellitus	1.35e-05	0.000239	CcSEcCtD
Fosinopril—Fatigue—Losartan—type 2 diabetes mellitus	1.34e-05	0.000238	CcSEcCtD
Fosinopril—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	1.34e-05	0.000237	CcSEcCtD
Fosinopril—Oedema—Ramipril—type 2 diabetes mellitus	1.34e-05	0.000237	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.33e-05	0.0024	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	1.33e-05	0.0024	CbGpPWpGaD
Fosinopril—Vomiting—Gliclazide—type 2 diabetes mellitus	1.33e-05	0.000236	CcSEcCtD
Fosinopril—Constipation—Losartan—type 2 diabetes mellitus	1.33e-05	0.000236	CcSEcCtD
Fosinopril—Pain—Losartan—type 2 diabetes mellitus	1.33e-05	0.000236	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.33e-05	0.00239	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.33e-05	0.00239	CbGpPWpGaD
Fosinopril—Rash—Gliclazide—type 2 diabetes mellitus	1.32e-05	0.000234	CcSEcCtD
Fosinopril—Dermatitis—Gliclazide—type 2 diabetes mellitus	1.32e-05	0.000234	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.32e-05	0.00238	CbGpPWpGaD
Fosinopril—Diarrhoea—Valsartan—type 2 diabetes mellitus	1.32e-05	0.000234	CcSEcCtD
Fosinopril—Urticaria—Irbesartan—type 2 diabetes mellitus	1.32e-05	0.000233	CcSEcCtD
Fosinopril—Shock—Ramipril—type 2 diabetes mellitus	1.31e-05	0.000233	CcSEcCtD
Fosinopril—Headache—Gliclazide—type 2 diabetes mellitus	1.31e-05	0.000233	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	1.31e-05	0.00236	CbGpPWpGaD
Fosinopril—Abdominal pain—Irbesartan—type 2 diabetes mellitus	1.31e-05	0.000232	CcSEcCtD
Fosinopril—Body temperature increased—Irbesartan—type 2 diabetes mellitus	1.31e-05	0.000232	CcSEcCtD
Fosinopril—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	1.31e-05	0.000232	CcSEcCtD
Fosinopril—Tachycardia—Ramipril—type 2 diabetes mellitus	1.3e-05	0.000231	CcSEcCtD
Fosinopril—Diarrhoea—Orlistat—type 2 diabetes mellitus	1.3e-05	0.000231	CcSEcCtD
Fosinopril—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	1.29e-05	0.000229	CcSEcCtD
Fosinopril—Feeling abnormal—Losartan—type 2 diabetes mellitus	1.28e-05	0.000228	CcSEcCtD
Fosinopril—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	1.27e-05	0.000226	CcSEcCtD
Fosinopril—Dizziness—Valsartan—type 2 diabetes mellitus	1.27e-05	0.000226	CcSEcCtD
Fosinopril—Anorexia—Ramipril—type 2 diabetes mellitus	1.27e-05	0.000226	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.27e-05	0.00229	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.27e-05	0.00229	CbGpPWpGaD
Fosinopril—Dizziness—Orlistat—type 2 diabetes mellitus	1.26e-05	0.000223	CcSEcCtD
Fosinopril—Asthenia—Metformin—type 2 diabetes mellitus	1.26e-05	0.000223	CcSEcCtD
Fosinopril—Hypotension—Ramipril—type 2 diabetes mellitus	1.25e-05	0.000221	CcSEcCtD
Fosinopril—Nausea—Gliclazide—type 2 diabetes mellitus	1.25e-05	0.000221	CcSEcCtD
Fosinopril—Pruritus—Metformin—type 2 diabetes mellitus	1.24e-05	0.00022	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.24e-05	0.00223	CbGpPWpGaD
Fosinopril—Urticaria—Losartan—type 2 diabetes mellitus	1.24e-05	0.000219	CcSEcCtD
Fosinopril—Body temperature increased—Losartan—type 2 diabetes mellitus	1.23e-05	0.000218	CcSEcCtD
Fosinopril—Abdominal pain—Losartan—type 2 diabetes mellitus	1.23e-05	0.000218	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.23e-05	0.00222	CbGpPWpGaD
Fosinopril—Vomiting—Valsartan—type 2 diabetes mellitus	1.23e-05	0.000217	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.22e-05	0.0022	CbGpPWpGaD
Fosinopril—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	1.22e-05	0.000216	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	1.22e-05	0.000216	CcSEcCtD
Fosinopril—Rash—Valsartan—type 2 diabetes mellitus	1.22e-05	0.000215	CcSEcCtD
Fosinopril—Dermatitis—Valsartan—type 2 diabetes mellitus	1.21e-05	0.000215	CcSEcCtD
Fosinopril—Vomiting—Orlistat—type 2 diabetes mellitus	1.21e-05	0.000214	CcSEcCtD
Fosinopril—Insomnia—Ramipril—type 2 diabetes mellitus	1.21e-05	0.000214	CcSEcCtD
Fosinopril—Headache—Valsartan—type 2 diabetes mellitus	1.21e-05	0.000214	CcSEcCtD
Fosinopril—Diarrhoea—Metformin—type 2 diabetes mellitus	1.2e-05	0.000213	CcSEcCtD
Fosinopril—Rash—Orlistat—type 2 diabetes mellitus	1.2e-05	0.000213	CcSEcCtD
Fosinopril—Paraesthesia—Ramipril—type 2 diabetes mellitus	1.2e-05	0.000213	CcSEcCtD
Fosinopril—Dermatitis—Orlistat—type 2 diabetes mellitus	1.2e-05	0.000213	CcSEcCtD
Fosinopril—Headache—Orlistat—type 2 diabetes mellitus	1.19e-05	0.000211	CcSEcCtD
Fosinopril—Dyspnoea—Ramipril—type 2 diabetes mellitus	1.19e-05	0.000211	CcSEcCtD
Fosinopril—Asthenia—Irbesartan—type 2 diabetes mellitus	1.19e-05	0.000211	CcSEcCtD
Fosinopril—Somnolence—Ramipril—type 2 diabetes mellitus	1.19e-05	0.00021	CcSEcCtD
Fosinopril—Dyspepsia—Ramipril—type 2 diabetes mellitus	1.18e-05	0.000208	CcSEcCtD
Fosinopril—Pruritus—Irbesartan—type 2 diabetes mellitus	1.17e-05	0.000208	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.16e-05	0.00209	CbGpPWpGaD
Fosinopril—Decreased appetite—Ramipril—type 2 diabetes mellitus	1.16e-05	0.000206	CcSEcCtD
Fosinopril—Dizziness—Metformin—type 2 diabetes mellitus	1.16e-05	0.000206	CcSEcCtD
Fosinopril—Fatigue—Ramipril—type 2 diabetes mellitus	1.15e-05	0.000204	CcSEcCtD
Fosinopril—Hypersensitivity—Losartan—type 2 diabetes mellitus	1.15e-05	0.000203	CcSEcCtD
Fosinopril—Nausea—Valsartan—type 2 diabetes mellitus	1.14e-05	0.000203	CcSEcCtD
Fosinopril—Constipation—Ramipril—type 2 diabetes mellitus	1.14e-05	0.000202	CcSEcCtD
Fosinopril—Diarrhoea—Irbesartan—type 2 diabetes mellitus	1.13e-05	0.000201	CcSEcCtD
Fosinopril—Nausea—Orlistat—type 2 diabetes mellitus	1.13e-05	0.0002	CcSEcCtD
Fosinopril—Asthenia—Losartan—type 2 diabetes mellitus	1.12e-05	0.000198	CcSEcCtD
Fosinopril—Vomiting—Metformin—type 2 diabetes mellitus	1.12e-05	0.000198	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.11e-05	0.002	CbGpPWpGaD
Fosinopril—Rash—Metformin—type 2 diabetes mellitus	1.11e-05	0.000196	CcSEcCtD
Fosinopril—Dermatitis—Metformin—type 2 diabetes mellitus	1.11e-05	0.000196	CcSEcCtD
Fosinopril—Pruritus—Losartan—type 2 diabetes mellitus	1.1e-05	0.000195	CcSEcCtD
Fosinopril—Feeling abnormal—Ramipril—type 2 diabetes mellitus	1.1e-05	0.000195	CcSEcCtD
Fosinopril—Headache—Metformin—type 2 diabetes mellitus	1.1e-05	0.000195	CcSEcCtD
Fosinopril—Dizziness—Irbesartan—type 2 diabetes mellitus	1.1e-05	0.000194	CcSEcCtD
Fosinopril—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	1.09e-05	0.000194	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.08e-05	0.00194	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.08e-05	0.00194	CbGpPWpGaD
Fosinopril—Diarrhoea—Losartan—type 2 diabetes mellitus	1.07e-05	0.000189	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.06e-05	0.00191	CbGpPWpGaD
Fosinopril—Urticaria—Ramipril—type 2 diabetes mellitus	1.06e-05	0.000188	CcSEcCtD
Fosinopril—Abdominal pain—Ramipril—type 2 diabetes mellitus	1.06e-05	0.000187	CcSEcCtD
Fosinopril—Body temperature increased—Ramipril—type 2 diabetes mellitus	1.06e-05	0.000187	CcSEcCtD
Fosinopril—Vomiting—Irbesartan—type 2 diabetes mellitus	1.05e-05	0.000187	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	1.05e-05	0.0019	CbGpPWpGaD
Fosinopril—Rash—Irbesartan—type 2 diabetes mellitus	1.04e-05	0.000185	CcSEcCtD
Fosinopril—Dermatitis—Irbesartan—type 2 diabetes mellitus	1.04e-05	0.000185	CcSEcCtD
Fosinopril—Nausea—Metformin—type 2 diabetes mellitus	1.04e-05	0.000185	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—AGT—type 2 diabetes mellitus	1.04e-05	0.00187	CbGpPWpGaD
Fosinopril—Headache—Irbesartan—type 2 diabetes mellitus	1.04e-05	0.000184	CcSEcCtD
Fosinopril—Dizziness—Losartan—type 2 diabetes mellitus	1.03e-05	0.000183	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.03e-05	0.00185	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—LEP—type 2 diabetes mellitus	1.02e-05	0.00183	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1e-05	0.0018	CbGpPWpGaD
Fosinopril—Vomiting—Losartan—type 2 diabetes mellitus	9.91e-06	0.000176	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	9.87e-06	0.00178	CbGpPWpGaD
Fosinopril—Hypersensitivity—Ramipril—type 2 diabetes mellitus	9.85e-06	0.000174	CcSEcCtD
Fosinopril—Nausea—Irbesartan—type 2 diabetes mellitus	9.84e-06	0.000174	CcSEcCtD
Fosinopril—Rash—Losartan—type 2 diabetes mellitus	9.83e-06	0.000174	CcSEcCtD
Fosinopril—Dermatitis—Losartan—type 2 diabetes mellitus	9.82e-06	0.000174	CcSEcCtD
Fosinopril—Headache—Losartan—type 2 diabetes mellitus	9.76e-06	0.000173	CcSEcCtD
Fosinopril—Asthenia—Ramipril—type 2 diabetes mellitus	9.59e-06	0.00017	CcSEcCtD
Fosinopril—Pruritus—Ramipril—type 2 diabetes mellitus	9.46e-06	0.000168	CcSEcCtD
Fosinopril—Nausea—Losartan—type 2 diabetes mellitus	9.26e-06	0.000164	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.17e-06	0.00165	CbGpPWpGaD
Fosinopril—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.14e-06	0.000162	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.13e-06	0.00164	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.04e-06	0.00163	CbGpPWpGaD
Fosinopril—Dizziness—Ramipril—type 2 diabetes mellitus	8.84e-06	0.000157	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	8.74e-06	0.00157	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—INS—type 2 diabetes mellitus	8.7e-06	0.00157	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	8.56e-06	0.00154	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	8.51e-06	0.00153	CbGpPWpGaD
Fosinopril—Vomiting—Ramipril—type 2 diabetes mellitus	8.5e-06	0.000151	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	8.47e-06	0.00152	CbGpPWpGaD
Fosinopril—Rash—Ramipril—type 2 diabetes mellitus	8.43e-06	0.000149	CcSEcCtD
Fosinopril—Dermatitis—Ramipril—type 2 diabetes mellitus	8.42e-06	0.000149	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	8.42e-06	0.00152	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	8.39e-06	0.00151	CbGpPWpGaD
Fosinopril—Headache—Ramipril—type 2 diabetes mellitus	8.37e-06	0.000148	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.17e-06	0.00147	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	8.11e-06	0.00146	CbGpPWpGaD
Fosinopril—Nausea—Ramipril—type 2 diabetes mellitus	7.94e-06	0.000141	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	7.58e-06	0.00137	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.37e-06	0.00133	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.92e-06	0.00125	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	6.84e-06	0.00123	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.42e-06	0.00116	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.48e-06	0.000986	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.09e-06	0.000916	CbGpPWpGaD
